18:09:10 EDT Sat 02 Nov 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:CALC - CALCIMEDICA INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CALC - Q0.13.30·3.841.03.51-0.19-5.1226.57618633.75  3.75  3.478.38  2.1419:49:18Oct 3015 min RT 2¢

Recent Trades - Last 10 of 863
Time ETExPriceChangeVolume
19:49:18Q3.6692-0.0308300
19:45:21Q3.6699-0.0301200
19:01:24Q3.6688-0.0312200
19:00:23Q3.665-0.03550
17:41:39Q3.67-0.03300
16:16:00Q3.47-0.235
16:00:01Q3.51-0.19247
16:00:01Q3.51-0.1922
16:00:01Q3.51-0.1914
15:59:54Q3.51-0.1925

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-30 22:11U:CALCNews ReleaseCalciMedica Announces Pricing of Public Offering of Common Stock
2024-10-30 16:50U:CALCNews ReleaseCalciMedica Announces Proposed Public Offering of Common Stock
2024-10-30 07:00U:CALCNews ReleaseCalciMedica to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP) at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
2024-10-28 16:05U:CALCNews ReleaseCalciMedica to Host a Call to Review Full Data Set, including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)
2024-10-16 08:00U:CALCNews ReleaseCalciMedica Announces Upcoming Late-Breaker Plenary Presentation at the American College of Gastroenterology (ACG) 2024 Annual Scientific Meeting
2024-09-03 08:00U:CALCNews ReleaseCalciMedica to Present at the H.C. Wainwright 26th Annual Global Investment Conference
2024-08-12 16:10U:CALCNews ReleaseCalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
2024-07-09 07:30U:CALCNews ReleaseCalciMedica Announces First Patient Enrolled in Phase 2 KOURAGE Trial of Auxora(TM) in Severe Acute Kidney Injury (AKI)
2024-07-08 08:00U:CALCNews ReleaseCalciMedica Announces Presentations at Two Upcoming Healthcare Investment Conferences
2024-07-01 08:00U:CALCNews ReleaseCalciMedica Set to Join Russell Microcap(TM) Index
2024-06-27 08:00U:CALCNews ReleaseCalciMedica Announces Positive Topline Data from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)
2024-06-26 16:05U:CALCNews ReleaseCalciMedica to Host Conference Call to Review Topline Data from Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis (AP)
2024-05-13 16:05U:CALCNews ReleaseCalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates
2024-05-07 08:00U:CALCNews ReleaseCalciMedica Announces Upcoming Presentation at Digestive Disease Week 2024
2024-04-24 08:00U:CALCNews ReleaseCalciMedica Announces Last Patient Enrolled in Phase 2b CARPO Trial of Auxora(TM) in Acute Pancreatitis
2024-03-28 07:00U:CALCNews ReleaseCalciMedica Reports 2023 Financial Results and Provides Clinical & Corporate Updates
2024-03-13 08:00U:CALCNews ReleaseCalciMedica Presents Data from Preclinical Studies of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
2024-02-28 18:57U:CALCNews ReleaseCalciMedica Announces Presentation of Data from a Preclinical Study of Auxora in Acute Kidney Injury at the 29th International AKI & CRRT Conference
2024-02-13 08:00U:CALCNews ReleaseCalciMedica Announces FDA Clearance of IND Application for Phase 2 Trial of Auxora ¢ „ ¢ for the Treatment of Severe Acute Kidney Injury
2024-02-07 16:05U:CALCNews ReleaseCalciMedica to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference